Schering AG
Müllerstrasse 172- 178
Berlin
D-13342
Germany
Tel: 49-30-468-11-11
Fax: +49-30-468-15305
Website: http://www.schering.de/
103 articles about Schering AG
-
Bayer AG Determines EUR 98.98 As Cash Compensation Per Schering AG Share
12/5/2006
-
Schering AG And Stanford University To Cooperate In The Field Of Molecular Imaging
11/28/2006
-
Schering AG Release: Betaferon(R) Approved In Australia For Earliest Stages Of Multiple Sclerosis
11/27/2006
-
Schering AG Maintains Strong Growth Momentum During First Nine Months Of 2006
11/27/2006
-
Warner Chilcott Licenses Worldwide Rights To Schering AG's SEGRA Compound For Dermatologic Indications And Announces Settlement Of Yaz(R) Patent Litigation
11/14/2006
-
Go-Ahead For Schering AG's Integration Into The Bayer Group
11/8/2006
-
Entry In The Commercial Register; Agreement Between Bayer AG And Schering AG In Force, Resolution Of Schering Extraordinary Stockholders' Meeting Implemented
10/31/2006
-
FDA Approves Berlex Inc.'s Betaseron(R) For Use After The First Event Suggestive Of Multiple Sclerosis
10/23/2006
-
Schering AG And Biogen Idec, Inc. (Massachusetts) Announce Start Of The ZEAL Phase III Clinical Trial With Anti-Cancer Drug Zevalin
10/5/2006
-
FDA Approves New Indication For Berlex Inc.'s YAZ(R) To Treat Emotional And Physical Symptoms Of Premenstrual Dysphoric Disorder (PMDD)
10/5/2006
-
Xanthus Pharmaceuticals, Inc. Expands Oncology Pipeline With Late-Stage Oral Fludarabine From Schering AG
10/3/2006
-
The Day In Review: ImClone Systems Incorporated Loses Erbitux Patent Fight
9/19/2006
-
Schering AG Licenses SEGRA Compound For Ophthalmic Use To Bausch & Lomb
9/18/2006
-
Schering AG And AstraZeneca PLC Form Strategic Alliance To Develop Novel Anti-Cancer Drug
9/15/2006
-
Stockholders Pave The Way For Bayer Schering Pharma
9/14/2006
-
Extraordinary Stockholders' Meeting Of Schering AG In Berlin
9/13/2006
-
Xanthus Pharmaceuticals, Inc. Licenses Novel Cancer Targeting Agents From Schering AG, Berlin
9/6/2006
-
Schering AG Says Drug Helps Fight Multiple Sclerosis
8/17/2006
-
Extraordinary Stockholders' Meeting Of Schering AG On September 13, 2006: Schering AG's Stockholders To Resolve On Domination And Profit And Loss Transfer Agreement With Bayer AG
8/4/2006
-
The Day In Review: Repligen Corporation Prevails Over ImClone Systems Incorporated In Court
7/31/2006